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SUMMARY 
A method has been developed to measure aldosterone receptors using rat kidney cytosol preparations. 
Addition of 0.1 M Na molybdate to homogenization buffer markedly diminished receptor inactivation, 
allowing for more accurate assessment of affinity and total number of receptors. Statistical analysis of 
Scatchard plots was used to resolve curvilinear plots into high affinity (type I) and a low affinity (type. II) 
components. Aldosterone and deoxycorticosterone compete most effectively for binding to type I sites, 
whereas dexamethasone competes most effectively for binding to type. II sites. Molybdate does not alter 
the location of the 8.0s peak on density gradient analysis. Assay of type I sites revealed 
47.7 + 1.7fmol/ml cytosol protein in male adrenalectomized rats. Constant of dissociation (Kn) was 
measured at 5.08 x 10-i M. Non-adrenalectomized male rats had 24.4 + 3.0 fmol/mg protein type I 
sites. Addition of molybdate to homogenization buffer combined with statistical analysis of curvilinear 
Scatchard plots allows for accurate and reproducible measurement of high affinity aldosterone receptors 
in rat kidney cytosol. 
INTRODU~ION AND METHODS 
Aldosterone binding proteins (ABP) have been identified in 
the cytoplasm of rat and human kidney tissue [l-3]. Quan- 
titation of the number and affinity of ABP has been com- 
plicated by the presence of two classes of sites; a high 
affinity, low capacity protein, thought to be the physiologic 
aldosterone receptor, and a low affinity, high capacity pro- 
tein. Funder et al. have labelled these type 1 and type II 
sites respectively [4]. Measurement of aldosterone recep- 
tors has also been complicated by their instability in a 
cytosol preparation [S]. For this reason, most studies have 
utilized tissue slice incubations, a technique which limits 
the number of incubations and renders quantitative analy- 
sis difficult because of high variability. 
Because sodium molybdate has been effective in prevent- 
ing glucocorticoid receptor inactivation [6], we have stabil- 
ized aldosterone receptors in cytosol preparations by the 
addition of sodium molybdate to homogenization buffer. 
Male Sprague-Dawley rats weighing 1%250gm were 
used. Adrenalectomy was performed under ether anesthesia 
l-3 days prior to assay. On the day of the assay, kidneys 
were perfused with iced isotonic solution (NaCl = 
0.133 M, KH*PO., = 0.006 M, CaCI, = 0.001 M, Tris-HCI 
= 0.005 M, M&I, = 0.0005 M, glucose = 0.005 M, 
pH = 7.4) via a catheter in the abdominal aorta, again 
using ether anesthesia. Kidneys were removed and minced 
and all subsequent procedures were performed at 4°C. 
Minces were homogenized in TSM buffer (Tris-HCI = 
0.1 M, sucrose = 0.25 M, Na molybdate = 0.1 M, pH = 
7.4) using a motor driven Teflon pestle and glass vial. The 
homogenate was centrifuged at 100,000g for 1 h, and the 
supernatant fraction was regarded as cytosol. 
Cytosol incubations were performed with [3H]-aldoster- 
one (85 Ci/mmol, New England Nuclear) in concentrations 
ranging from 1.63 x IO- “M to 5.33 x IO-* M in a total 
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volume of 300~1. Parallel incubations with excess un- 
labelled aldosterone (1.33 x low5 M) were performed with 
each concentration of [3H]-aldosterone. Incubation for 
40 min at 22°C was followed by a charcoal separation step. 
Dextran-coated charcoal [IO gm of activated charcoal 
(Sigma), 250mg Dextran T-80 (Pharmacia) per liter of 
TSM buffer], 0.5~~. was added to each incubation tube. 
vortexed, and centrifuged at 3000~ for 10 min. A 0.5 cc 
portion of the supernatant fraction was counted. 
Nonspecific binding was defined as, [“HI-aldosterone 
bound in the presence of 1.33 x IO-’ M unlabelled aldos- 
terone. Specific binding was calculated by subtracting non- 
specific binding from total binding. Cytosol protein was 
determined by the method of Lowry[II], and curvilinear 
Scatchard plots were analyzed by the method of Priore and 
Rosenthal[S]. This analysis allowed for determination of 
the slope and x-intercept of both type I and type II lines. 
The effect of molybdate in blocking receptor inactivation 
was assessed by preparing cytosol in -homogenization 
buffer with (TSMI or without fTS1 the addition of Na 
molybdate. Cytosdl was also prepared in TS buffer with 
0.1 M NaCl. Cytosols were allowed to stand at 22°C for 0, 
20, 40, and 60min. then incubated with 1.33 x 10d9M 
[“HI-aldosterone. 
Binding of various steroids to ABP was assessed by incu- 
bating cytosol prepared in TSM buffer with 3.3 x IO- lo M 
or 3.3 x lo-sM C3H]-aldosterone along with increasing 
concentrations of unlabelled steroids. For each steroid, six 
concentrations were used, each point representing the 
mean of four experiments. Duplicate incubations were per- 
formed with 1.33 x IO-‘M unlabelled aldosterone and 
specific binding was expressed as percent of total specific 
binding seen in the absence of competing unlabelled 
steroid. 
Gradient analysis of receptors in TS and TSM buffer 
was performed. Cytosol was incubated with 3.3 x 10m9 M 
[3H]-aldosterone. and 400 ~1 was added to a pellet of dex- 
tran charcoal, vortexed, and centrifuged at 3OOOg for 
10 min. A volume of 200 ~1 of cytosol was then layered on 
to a linear l&30% sucrose gradient (5.0ml). Gradients 
835 
836 Short Communication 
(a) 9 I (b) 
Fig. 1. Effect of mdybdate upon E3H’J-aldosterone binding to ABP. (a) Scatchard analysis of ABP with 
or without Na molybdate. (b) Inactivation of ABP at 22°C. Cytosol prepared with or without 0.1 M Na 
molybdate or 0.l.M NaCl was allowed to stand at 22°C for 0 to 60min prior to incubation with 
[3H]-aldosterone. Specific binding is expressed as the % of binding seen at 0 time, and values given are 
the means of three experiments +SEM Initial binding with TSM buffer was 40.4 fmol/mg protein, with 
T’S buffer was 12.2 fmol/mg protein, and with 0.1 M NaCl was 1 I.7 fmol/mg protein. 
were centrifuged at 300,000g for 14.5 h at 4°C using a 
SW65 rotor in a Beckman L2-65B ultracentrifuge, then 
separated into two drop fractions and counted. Bovine 
serum albumin was layered on a separate gradient as a 
standard marker. 
RESULTS AND DISCUSSION 
Scatchard analysis of binding with TSM buffer showed 
markedly increased binding when compared to experi- 
ments using TS buffer (Fig. 1). Statistical analysis for type I 
sites in adrenalectomized rats (n = 7) revealed 
46.7 k 1.7 fmol/mg cytosol protein using TSM buffer, and 
35.1 f 2.6fmol/mg protein using TS buffer (n = 8) 
(P -z 0.005). In addition, the apparent affinity of type I sites 
for aldosterone was markedly enhanced. Using molybdate, 
the measured K, was 5.08 x IO- lo M, which was signifi- 
cantly less than that for type I sites using TS buffer, 
Ku = 3.23 x 10T9M (P < 0.001). Using TSM buffer, 
intact animals had 24.4 f 3.0 fmoI/mg protein type I sites, 
a significant decrease compared to adrenalectomized ani- 
mals (P < 0.001). while affinity was unchanged. The results 
of inactivation experiments are also shown in Fig. 1. Dur- 
ing one hour at 22°C. cytosol prepared with molybdate 
had only a 16% decrease in binding capacity. while cytosol 
prepared without molybdate Iost 90% of binding capacity. 
The ability of various unlabelled steroids to compete for 
[3H]-aldosterone binding sites is shown in Table I. 
Gradient analysis using both TS and TSM buffer revealed 
a major peak with an 8.0s sedimentation coefficient 
(Fig. 2). 
Nielsen et al. have shown that glucocorticoid receptors 
in thymocyte cytosol preparations appear to be inactivated 
by a phosphatase enzyme system, and that sodium molyb- 
date and other phosphatase enzyme inhibitors are effective 
in preventing this inactivation [6]. In this study, sodium 
molybdate has also been shown to protect ABP from inac- 
tivation. 
The apparent increase in affinity seen with molybdate 
can be explained by the observation that filled receptors 
are more resistant to inactivation than are unoccupied 
receptors [YJ. Incubations with smaller amounts of aldos- 
terone result in more receptor inactivation, increasing the 
slope of the Scatchard plot and decreasing the calculated 
affinity [9]. 
The equal affinity of aldosterone and DOC for binding 
to type I sites has been seen in some other aldosterone 
receptor systems E4. IO]. Glucocorticoids and progesterone 
had about 30% of the affinity of aldosterone in this study, 
whereas other cytosol assays have found progesterone and 
corticosterone to be 28% and 25% as effective as aldoster- 
one [ 1 I], and dexamethasone to be SOye as active as aldos- 
terone in competing for [3H]-a1dosterone binding 151. 
Higgins et al. found dexamethasone and cortisol both dis- 
Table 1. Inhibition of [3H]-aldosterone binding to high affinity (type I) and low 
affinity (type II) sites by nonradioactive steroids 
Steroids 
Type I sites Type II sites 
Concentration Relative Concentration Relative 
(nM) inhibition (nM) inhibition 
Aldosterone 3.0 f 0.05 1.00 54.0 f 0.05 1.00 
Deoxycorticosterone 3.0 + 0.02 1.00 23.1 It 2.6 2.34 
Spironolactone 9.2 + 1.4 0.33 228 + 9.0 0.24 
Progesterone 10.8 + 0.6 0.28 61.8 + 3.6 0.87 
Corticosterone 11.2 & 0.4 0.27 55.0 + 2.2 0.98 
Dexamethasone 11.3 f 0.6 0.27 8.6 f 0.3 6.28 
Estradiol 553 & 50 0.005 
Cytosol was incubated with 3.3 x IO-“M E3H]-aldosterone (80-85x of 
binding is to high affh-rity sites) or 3.3 x 10-a M [3H]-aldosterone (75-80x of 
binding is to low affinity sites). Concentrations of nonradioactive steroids 
required to displace 50% of bound [“HI-aldosterone are listed. 
Relative inhibition = aldosterone concentration at 50% displacement/steroid 
concentration at 50% displacement. 
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Fig. 2. Sucrose density gradient analysis of ABP. Cytosol was incubated with 3.3 x 1O-9 M [3H]-aldos- 
terone using either TSM (a) or TS (b) buffer. The major peak is at 8.0s for both experiments. Closed 
circles represent total binding, open circles represent nonspecific binding. Protein concentration for both 
cytosols was 25 mg/ml. Calculated sedimentation coefficient of BSA = 4.3s. 
placed [3H]-aldosterone about IO% as well as unlabelled 
aldosterone [IO]. Corticosterone had 10% of the affinity of 
aldosterone in a slice assay preparation [4]. 
The binding affinities of aldosterone and other steroids 
do not correspond closely with their potency in mineralo- 
corticoid bioassay systems. In such systems, DOC has 
about 10% of the activity of aldosterone and glucocorti- 
coids are I to 2% as active [l2]. Part of this discrepancy 
can be explained by increased binding of DOC and cor- 
ticosterone to corticosteroid binding globulin in uiuo com- 
pared to aldosterone [4, 13-J. 
The smaller numbers of receptors in intact animals com- 
pared to adrenalectomized animals is not surprising. This 
smaller number is most probably secondary to in uiuo 
binding of receptors to aldosterone, rendering these rece.p- 
tors unavailable for ia vitro binding. Receptor measure- 
ments using molybdate stabilized cytosol must be inter- 
preted cautiously, for addition of molybdate may alter the 
behavior of receptors as is seen for glucocorticoid recep 
tors [14]. The use of a cytosol preparation for assessment 
of renal aldosterone receptors should allow for easier de- 
termination of receptor number and affinity during physio- 
logic and pathologic alterations. 
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